These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 31359359

  • 1. Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B.
    Chuaypen N, Payungporn S, Poovorawan K, Chotiyaputta W, Piratvisuth T, Tangkijvanich P.
    Virus Genes; 2019 Oct; 55(5):610-618. PubMed ID: 31359359
    [Abstract] [Full Text] [Related]

  • 2. Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.
    Yang HC, Chen CL, Shen YC, Peng CY, Liu CJ, Tseng TC, Su TH, Chuang WL, Yu ML, Dai CY, Liu CH, Chen PJ, Chen DS, Kao JH.
    Hepatology; 2013 Mar; 57(3):934-43. PubMed ID: 23112104
    [Abstract] [Full Text] [Related]

  • 3. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
    Ma XY, Han T, Pei YZ, Zhao ZG, Gao YT, Li Y, Jing L.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
    [Abstract] [Full Text] [Related]

  • 4. Deep sequencing of hepatitis B virus basal core promoter and precore mutants in HBeAg-positive chronic hepatitis B patients.
    Yan L, Zhang H, Ma H, Liu D, Li W, Kang Y, Yang R, Wang J, He G, Xie X, Wang H, Wei L, Lu Z, Shao Q, Chen H.
    Sci Rep; 2015 Dec 09; 5():17950. PubMed ID: 26647737
    [Abstract] [Full Text] [Related]

  • 5. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
    Bayliss J, Yuen L, Rosenberg G, Wong D, Littlejohn M, Jackson K, Gaggar A, Kitrinos KM, Subramanian GM, Marcellin P, Buti M, Janssen HLA, Gane E, Sozzi V, Colledge D, Hammond R, Edwards R, Locarnini S, Thompson A, Revill PA.
    Gut; 2017 Nov 09; 66(11):2013-2023. PubMed ID: 27534671
    [Abstract] [Full Text] [Related]

  • 6. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
    Tangkijvanich P, Komolmit P, Mahachai V, Sa-nguanmoo P, Theamboonlers A, Poovorawan Y.
    J Clin Virol; 2009 Oct 09; 46(2):117-23. PubMed ID: 19651540
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
    Zhong YW, Di FL, Liu C, Zhang XC, Bi JF, Li YL, Wu SQ, Dong H, Liu LM, He J, Shi YM, Zhang HF, Zhang M.
    Clin Microbiol Infect; 2016 Apr 09; 22(4):379.e1-379.e8. PubMed ID: 26577140
    [Abstract] [Full Text] [Related]

  • 8. Association of characteristics of HBV quasispecies with hepatitis B surface antigen seroconversion after pegylated interferon-α-2a treatment in child patients.
    Yang J, Yang G, He H, Ning L, Liu Z, Fu Q, Chen H, Deng H, Wang Z, Luo K.
    Antivir Ther; 2018 Apr 09; 23(7):567-574. PubMed ID: 30095435
    [Abstract] [Full Text] [Related]

  • 9. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
    Sonneveld MJ, Rijckborst V, Cakaloglu Y, Simon K, Heathcote EJ, Tabak F, Mach T, Boucher CA, Hansen BE, Zeuzem S, Janssen HL.
    Antivir Ther; 2012 Apr 09; 17(1):9-17. PubMed ID: 22267464
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus basal core promoter mutations A1762T/G1764A are associated with genotype C and a low serum HBsAg level in chronically-infected HBeAg-positive Chinese patients.
    Yan CH, Zhao CY, Ding H, Peng YQ, Jin PY, Yan L, Zhuang H, Li T.
    Antiviral Res; 2012 Nov 09; 96(2):108-14. PubMed ID: 22960603
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of basal core promoter and precore mutations in Chinese chronic hepatitis B patients and correlation with serum HBeAG titers.
    Qin Y, Zhang J, Mao R, Guo H, Yin Y, Wu X, Weng X, Wands J, Tong S.
    J Med Virol; 2009 May 09; 81(5):807-14. PubMed ID: 19319958
    [Abstract] [Full Text] [Related]

  • 12. Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patients.
    Jansen L, Welkers MRA, van Dort KA, Takkenberg RB, Lopatin U, Zaaijer HL, de Jong MD, Reesink HW, Kootstra NA.
    Antiviral Res; 2017 Sep 09; 145():87-95. PubMed ID: 28754258
    [Abstract] [Full Text] [Related]

  • 13. Pre-core/basal-core promoter and reverse transcriptase mutations in chronic HBV infected-patients.
    Xu L, Chen EQ, Lei J, Liu L, Zhou TY, Gao Z, Tang H.
    Hepatogastroenterology; 2012 Sep 09; 59(113):212-5. PubMed ID: 22251541
    [Abstract] [Full Text] [Related]

  • 14. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
    Kamijo N, Matsumoto A, Umemura T, Shibata S, Ichikawa Y, Kimura T, Komatsu M, Tanaka E.
    World J Gastroenterol; 2015 Jan 14; 21(2):541-8. PubMed ID: 25593470
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus genotype B with G1896A and A1762T/G1764A mutations is associated with hepatitis B related acute-on-chronic liver failure.
    Xiao L, Zhou B, Gao H, Ma S, Yang G, Xu M, Abbott WG, Chen J, Sun J, Wang Z, Hou J.
    J Med Virol; 2011 Sep 14; 83(9):1544-50. PubMed ID: 21739444
    [Abstract] [Full Text] [Related]

  • 16. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
    Sonneveld MJ, Rijckborst V, Zeuzem S, Heathcote EJ, Simon K, Senturk H, Pas SD, Hansen BE, Janssen HL.
    Hepatology; 2012 Jul 14; 56(1):67-75. PubMed ID: 22307831
    [Abstract] [Full Text] [Related]

  • 17. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
    Liu S, Zhang H, Gu C, Yin J, He Y, Xie J, Cao G.
    J Natl Cancer Inst; 2009 Aug 05; 101(15):1066-82. PubMed ID: 19574418
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.